Indevus books $50m payment
August 13, 2007 08:45 AM
E-mail|
|Comments
()|
Text size
–
+
Indevus Pharmaceuticals Inc. of Lexington said today it has received a $49.9 million milestone payment from its US partner for Sanctura and Sanctura XR, treatments for overactive bladder.
The payment follows Aug. 3 approval by the Food & Drug Administration of Sanctura XR, the once-daily formulation of Sanctura, Indevus said.
The milestone payment was from Esprit Pharma of New Jersey, Indevus's partner in the United States for Sanctura and Sanctura XR, Indevus said.
(By Chris Reidy, Globe staff)
Comment
Permalink
E-mail
